GSTP1 and prostate carcinoma: Studies have shown that glutathione-s-transferase—π (GSTP1) promoter hypermethylation is the most common somatic genome alteration during prostate cancer development (Lee et al, 1994; Goessl, 2000; Kang et al, 2004).